Medscape Hematology-Oncology Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Gilead's Trodelvy Fails to Meet Main Goal in Lung Cancer Trial Gilead's Trodelvy Fails to Meet Main Goal in Lung Cancer Trial
Gilead Sciences said on Monday its drug, Trodelvy, failed to significantly improve survival for previously treated patients with advanced non-small cell lung cancer (NSCLC)...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Adaptive SABR Boost Shows Promise in Advanced NSCLC Adaptive SABR Boost Shows Promise in Advanced NSCLC
Radiation dose-escalation combined with stereotactic ablative radiotherapy may improve locoregional control in patients with NSCLC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Call to Action: Fix the Drug Shortages to Save Patients Call to Action: Fix the Drug Shortages to Save Patients
Dr Maurie Markman discusses widespread shortages of anticancer chemotherapeutic agents.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Oncologists Sound the Alarm About Rise of White Bagging Oncologists Sound the Alarm About Rise of White Bagging
More states are barring the practice of white bagging, while oncology groups and insurance advocates continue to debate its impacts on costs.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval
Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Coming Soon: The First mRNA Vaccine for Melanoma? Coming Soon: The First mRNA Vaccine for Melanoma?
Results of a phase 2b trial were favorable, and Moderna suggests that an mRNA vaccine for melanoma could be available in 2025.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Radiation Oncologists Fight for Payment Reform Amid Cuts Radiation Oncologists Fight for Payment Reform Amid Cuts
Since 2013, radiation oncologists have seen a 23% drop in Medicare payments for radiation therapy services.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 16, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

FDA Approves Pembrolizumab for Stage 3/4a Cervical Cancer FDA Approves Pembrolizumab for Stage 3/4a Cervical Cancer
The new approval marks the 40th oncology indication for pembrolizumab across 19 cancer types, including two previous metastatic cervical cancer approvals.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 16, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Is Axillary Surgery for Abemaciclib Candidacy Overused? Is Axillary Surgery for Abemaciclib Candidacy Overused?
Many women with HR –positive, HER2–negative breast cancer may be exposed to unnecessary axillary surgery, new data show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Medical Cannabis for Chronic Pain Tied to Arrhythmia Risk Medical Cannabis for Chronic Pain Tied to Arrhythmia Risk
Medical cannabis for chronic pain was associated with an increased risk of developing arrhythmia in a large Danish study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 12, 2024 Category: Cancer & Oncology Tags: Cardiology Source Type: news

HPV Vax Tied to Lower Odds of Cervical Lesion Progression HPV Vax Tied to Lower Odds of Cervical Lesion Progression
Vaccination status may help clinicians assess the likelihood that cervical intraepithelial neoplasia grade 2 will progress.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 11, 2024 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health Source Type: news

FDA Rejects GI Cancer Drug Over Manufacturing Issues FDA Rejects GI Cancer Drug Over Manufacturing Issues
The manufacturer of the drug, zolbetuximab, says it is working closely with the FDA to resolve the issues.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 10, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Lung Cancer Screening: Unnecessary for Some Patients? Lung Cancer Screening: Unnecessary for Some Patients?
A new study found higher rates of invasive procedures and complications after annual lung cancer screenings than shown in previous research.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 10, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care Source Type: news

Using GPT-4 to Efficiently Match Patients to Clinical Trials Using GPT-4 to Efficiently Match Patients to Clinical Trials
An expert on artificial intelligence discusses a new tool that can more efficiently match cancer patients with clinical trials.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 10, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

What Prompts a Post-Childhood'Survival Cliff' in ALL? What Prompts a Post-Childhood'Survival Cliff' in ALL?
Experts explore why children with acute lymphoblastic leukemia fare well with current treatment options, while adolescents and younger adults still face high mortality rates.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 10, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news